Physician profile
Sudhakar Reddy
NPI 1295763753
$1,277.20
in general payments reported to CMS, 2019-2025
17 companies · $71.54 in 2025
The $71.54 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $128 · 2021: $237 · 2022: $234 · 2023: $203 · 2024: $261 · 2025: $71.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $467.14 | 2020-2023 | |
| Gilead Sciences, INC. | $137.89 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $118.15 | 2024 | Terlivaz |
| Pentax of America, INC. | $99.21 | 2024 | Pentax Medical, C2 Cryoballoon Focal Controller, C2 Cryoballoon |
| Takeda Pharmaceuticals U.S.A., INC. | $67.33 | 2020-2023 | Entyvio |
| Braintree Laboratories, INC. | $58.32 | 2020-2021 | |
| Intercept Pharmaceuticals, INC. | $52.29 | 2019-2023 | Ocaliva |
| Celgene Corporation | $52.10 | 2023 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.85 | 2022-2024 | Xifaxan |
| Janssen Biotech, INC. | $41.76 | 2022 | |
| Daiichi Sankyo INC. | $24.95 | 2021 | |
| Coloplast Corp | $23.77 | 2024 | |
| Novo Nordisk INC | $20.47 | 2025 | Wegovy |
| Nestle Healthcare Nutrition INC. | $16.85 | 2020 | |
| Lilly USA, LLC | $15.87 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $15.51 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudhakar Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.